Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
May 7, 2026
Reporting period
Not applicable
Filed with the SEC
May 11, 2026
CEOTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000318154-26-000084
Filed / recorded
May 11, 2026, 11:39 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
AMGEN INC
Issuer CIK
318154
Ticker
AMGN
Reporting person
Robert A Bradway
Relationship
Director, Officer
Officer title
Chairman, CEO and President
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
May 7, 2026
Transaction code
F
Shares / units
2,079
Price per share
$331.11
Acquired / disposed
Disposed (D)
Shares owned after
505,160
Ownership form
Direct
Amendment
No
Footnotes from the filing
These shares include 1,273 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
